XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
   Non-Hodgkin's Lymphoma
   Multiple Myeloma
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Blood Channel
subscribe to Blood newsletter

Latest Research : Cancer : Blood

   DISCUSS   |   EMAIL   |   PRINT
Clinical significance of diminished protein Z in plasma
Jan 9, 2005, 15:18, Reviewed by: Dr.



 
The clinical significance of diminished protein Z in plasma is controversial. Studies in mice demonstrated that deficiency of protein Z dramatically increases the prothrombotic tendency of factor V Leiden mutation.

This finding was confirmed by initial results in humans, indicating that thromboembolism in factor V Leiden patients with lowered protein Z level occurs earlier than in patients with normal protein Z levels.

Consequently, the aim of our present study was to find out whether genetic alterations of protein Z were demonstrated in patients with factor V Leiden mutation and early onset of thromboembolic disease.

DNA-sequencing of the protein Z gene was performed in two patients with factor V Leiden mutation, early onset of thromboembolism, and lowered protein Z levels. In both patients, R255H substitution of the protein Z gene was identified.

Subsequently, the R255H substitution was also found in 12 of 132 additional patients. Patients presenting with the R255H substitution in addition to factor V Leiden mutation showed thromboembolic events more frequently than factor V Leiden patients without R255H substitution of the protein Z gene.

In conclusion, R255H substitution of the protein Z gene seems to influence clinical symptoms of thromboembolism in factor V Leiden patients.

 

- British Journal of Haematology,Volume 128 Issue 2 Page 248 - January 2005
 

British Journal Of Haematology

 
Subscribe to Blood Newsletter
E-mail Address:

 

Bettina Kemkes-Matthes1, Karl J. Matthes1, Masayoshi Souri2, Shiori Koseki-Kuno2 and Akitada Ichinose

Related Blood News

Medication errors affect children's leukemia treatment
JAK-STAT pathway inhibitors are likely to be effective against some leukemias
HO-1 in sickle cell disease
Dasatinib treats resistant cases of CML
HBZ protein enhance ability of HTLV-1 to establish persistent infection
Gene expression signature for Burkitt lymphoma identified
Bcr-Abl mutation and the loss of Arf genes triggers an aggressive form of ALL
New simple and inexpensive test for follow-up of acute lymphoblastic leukemia (ALL)
miRNAs abnormal signalling may lead to platelet-related leukemias
DNA itself can act as a mutagen


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us